ATOX1 and cancer: In particular, the recent discovery of the mechanism of ‘copper death’ (cuproptosis) has highlighted new opportunities for targeting copper homeostasis to induce cancer-specific death [24], providing a more robust theoretical basis for targeting copper metabolism through ATOX1.